Vaxxinity, Inc.
NASDAQ:VAXX
0.09 (USD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.066 | 0.557 | 0 |
| Cost of Revenue
| 2.234 | 1.684 | 1.937 | 0.052 | 0.107 |
| Gross Profit
| -2.234 | -1.684 | -1.871 | 0.505 | -0.107 |
| Gross Profit Ratio
| 0 | 0 | -28.348 | 0.907 | 0 |
| Reseach & Development Expenses
| 33.665 | 47.627 | 71.379 | 20.57 | 10.656 |
| General & Administrative Expenses
| 0.022 | 28.352 | 51.825 | 12.217 | 3.005 |
| Selling & Marketing Expenses
| 22.364 | 0 | 0 | 0 | 0 |
| SG&A
| 22.386 | 28.352 | 51.825 | 12.217 | 3.005 |
| Other Expenses
| 0 | 0 | -8.365 | -5.761 | -0.027 |
| Operating Expenses
| 56.051 | 75.979 | 123.204 | 32.787 | 13.661 |
| Operating Income
| -58.285 | -75.979 | -125.075 | -32.282 | -13.661 |
| Operating Income Ratio
| 0 | 0 | -1,895.076 | -57.957 | 0 |
| Total Other Income Expenses Net
| 1.351 | 0.757 | -12.1 | -7.675 | -0.502 |
| Income Before Tax
| -56.934 | -75.222 | -137.175 | -39.957 | -14.163 |
| Income Before Tax Ratio
| 0 | 0 | -2,078.409 | -71.736 | 0 |
| Income Tax Expense
| 0 | -0.012 | 0.84 | -4.58 | 0.056 |
| Net Income
| -56.934 | -75.21 | -138.015 | -35.377 | -14.219 |
| Net Income Ratio
| 0 | 0 | -2,091.136 | -63.513 | 0 |
| EPS
| -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
| EPS Diluted
| -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
| EBITDA
| -56.051 | -73.036 | -123.964 | -37.326 | -13.581 |
| EBITDA Ratio
| 0 | 0 | -1,878.242 | -67.013 | 0 |